20349 ⎘
Medicinal preparations containing organic active ingredients; Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole; Thiazoles condensed with heterocyclic ring systems
Sub-classes:SPIROMACROCYCLIC OREXIN 2 RECEPTOR AGONISTS
#2PAPD5 INHIBITORS AND METHODS OF USE THEREOF
#3Anti-Giardial Compounds
#4PLASMODIUM FALCIPARUM BLOOD STAGE INHIBITORS
#5NAMPT MODULATORS, PREPARATIONS, AND USES THEREOF
#6INDANE AND COUMARAN DERIVATIVES AS FAST SKELETAL MUSCLE MYOSIN INHIBITORS
#7N-(3-(BENZO[B]THIOPHENE-2-CARBOXAMIDO)-PHENYL)-2,3-DIHYDROBENZO[B][1,4]DIOXINE-6-CARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS LACTATE/ATP PRODUCTION INHIBITORS FOR THE TREATMENT OF CANCER
#8Compositions for Modulating Lipoxygenase and Methods of Using Same
#9MACROCYCLIC COMPOUNDS, COMPOSITIONS, AND METHODS OF USING THEREOF
#10MACROCYCLIC COMPOUNDS, COMPOSITIONS, AND METHODS OF USING THEREOF
#11METHOD FOR DETECTING OR TREATING TRIPLE NEGATIVE BREAST CANCER
#12BENZOTHIAZOLE ANAOLOGUES AND USE THEREOF AS BOOSTERS OF ANTI TUBERCULOSIS DRUGS
#13INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE 1 (IDO1) AND TRYPTOPHAN 2,3-DIOXYGENASE (TDO) AND METHODS OF USING SAME
#14INDAZOLE CONTAINING MACROCYCLES AND THEIR USE
#15C-MYC MRNA TRANSLATION MODULATORS AND USES THEREOF IN THE TREATMENT OF CANCER
#16COMPOSITIONS USEFUL FOR MODULATING SPLICING
#17COMPOSITIONS USEFUL FOR MODULATING SPLICING
#18MRGPRX2 ANTAGONISTS, PHARMACEUTICAL COMPOSITION INCLUDING MRGPRX2 ANTAGONIST, AND METHOD OF TREATING MRGPRX2-MEDIATED DISEASE OR DISORDER
#19MRGPRX2 ANTAGONISTS, PHARMACEUTICAL COMPOSITION INCLUDING MRGPRX2 ANTAGONIST, AND METHOD OF TREATING MRGPRX2-MEDIATED DISEASE OR DISORDER
#20NOVEL BENZOTHIAZOLE DERIVATIVES
#21RIPK1 INHIBITORS AND METHODS OF USE
#22ALDH2 INHIBITORS AND METHODS OF USE THEREOF
#23PHARMACEUTICAL COMPOUNDS AND COMPOSITIONS AS c-KIT KINASE INHIBITORS
#24SPIROMACROCYCLIC OREXIN 2 RECEPTOR AGONISTS
#25MACROCYCLIC COMPOUNDS, COMPOSITIONS, AND METHODS OF USING THEREOF
#26NEW ANTIVIRAL TRIAZOLE DERIVATIVES, THEIR SYNTHESIS AND THEIR USE FOR TREATMENT OF MAMMALIAN VIRAL INFECTIONS
#27ANTIBACTERIAL AGENTS
#28COMPOUNDS FOR USE IN THE TREATMENT OF CANCER AND INFLAMMATORY CONDITIONS
#29COMPOSITIONS AND METHODS FOR INHIBITING FSP1
#30HDAC INHIBITOR OKI-179 IN COMBINATION WITH BINIMETINIB FOR THE TREATMENT OF CANCER
#31THIAZOLE COMPOUNDS AND METHODS OF USE THEREOF
#32THIOSTREPTON-INSPIRED COMPOUNDS FOR TREATMENT OF CANCER AND PREPARATION THEREOF
#33C-MYC MRNA TRANSLATION MODULATORS AND USES THEREOF IN THE TREATMENT OF CANCER
#34SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS
#35cGAS ANTAGONIST COMPOUNDS
#36METHODS FOR VASCULAR REGENERATION AND WOUND TREATMENT
#37BACTERIAL DNA GYRASE INHIBITORS AND METHODS OF USE THEREOF
#38DERIVATIVES OF TURBINMICIN AS ANTIFUNGAL AGENTS
#39Methods for Preventing Ectopic Brain Mineralization in Alzheimer's Disease and Dementias
#40ANTIBACTERIAL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF TREATING BACTERIAL INFECTIONS
#41Pharmaceutical Compounds and Compositions as C-Kit Kinase Inhibitors
#42BCL-XL INHIBITORS
#43BAX ACTIVATORS AND USES THEREOF IN CANCER THERAPY
#44SPIROMACROCYCLIC OREXIN 2 RECEPTOR AGONISTS
#45Methods for Preventing Ectopic Brain Mineralization in Alzheimer's Disease and Dementias
#462-AZABICYCLO[2.2.1]HEPTANE KRAS INHIBITORS
#47METHOD FOR ENHANCING INNATE IMMUNE RESPONSE
#48DEVELOPMENT AND OPTIMIZATION OF THIOCHROMENOTHIAZOLE-BASED MSUT2 INHIBITORS AS CANDIDATES FOR THE TREATMENT OF TAUOPATHY
#49USE OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA COACTIVATOR 1-ALPHA (PGC1ALPHA) AGONISTS TO IMPROVE EX VIVO EXPANSION OF TUMOR INFILTRATING LYMPHOCYTES (TILS)
#50MITOFUSIN ACTIVATORS AND USES THEREOF
#51PATEAMINE A DERIVATIVE FOR TREATING PANCREATIC CANCER
#521,4-sulfur-bridged polycyclic compounds containing dihydrobenzofuran structure, its preparation method and application thereof
#53MACROCYCLIC TAK1 INHIBITORS
#54TRICYCLIC HETEROCYCLES
#55MODULATORS OF MAS-RELATED G-PROTEIN RECEPTOR X4 AND RELATED PRODUCTS AND METHODS
#56MACROCYCLIC LRRK2 KINASE INHIBITORS
#57TEAD INHIBITORS
#585-(5-(PIPERIDIN-4-YL)THIENO[3,2-C]PYRAZOL-2-YL]INDAZOLE DERIVATIVES AND RELATED COMPOUNDS AS MODULATORS FOR SPLICING NUCLEIC ACIDS AND FOR THE T
#59COMPOUNDS FOR USE IN THE TREATMENT OF HYPERPROLIFERATIVE DISORDERS
#60SPIRO-CONTAINING DERIVATIVE, AND PREPARATION METHOD THEREFOR AND USE THEREOF
#61Antibacterial Compounds
#62METHOD FOR PREDICTING A SUBJECT'S RESPONSE TO SLC MODULATOR THERAPY
#63cGAS antagonist compounds
#64RIPK1 INHIBITORS AND METHODS OF USE
#65BACTERIAL DNA GYRASE INHIBITORS AND METHODS OF USE THEREOF
#66RING-FUSED 2-PYRIDONE COMPOUNDS, METHODS FOR PREPARATION THEREOF AND THEIR USE IN THE TREATMENT AND/OR PREVENTION OF A DISEASE INVOLVING GRAM-POSITIVE BACTERIA
#67Methods and compositions to treat cancer
#68METHOD FOR DETECTING OR TREATING TRIPLE NEGATIVE BREAST CANCER
#69HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
#70COMPOSITIONS AND METHODS FOR ACTIVATING SIGNALING THROUGH THE CB2 CANNABINOID RECEPTOR FOR TREATING AND PREVENTING LYSOSOMAL STORAGE DISEASES AND DISORDERS
#71NOVEL ALKYNE DERIVATIVES
#72Bacterial DNA gyrase inhibitors and methods of use thereof
#73CAR AND NRF2 DUAL ACTIVATOR AGENTS FOR CYCLOPHOSPHAMIDE-BASED AND DOXORUBICIN-BASED TREATMENTS OF CANCER
#74Suppression of Neuroinflammation and Composition and Method Therefore
#75COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY
#76METHOD OF TREATING VIRUS INFECTION USING A TLR7 AGONIST
#77Antibacterial compounds
#78THIAZOLE CARBOXAMIDE COMPOUNDS AND USE THEREOF FOR THE TREATMENT OF MYCOBACTERIAL INFECTIONS
#79NOVEL COMPOUNDS
#80C-MYC MRNA TRANSLATION MODULATORS AND USES THEREOF IN THE TREATMENT OF CANCER
#81CGAS antagonist compounds
#82BAX activators and uses thereof in cancer therapy
#83INHIBITORS OF MONOCARBOXYLATE TRANSPORTERS FOR CANCER IMMUNOTHERAPY
#84Treatment of vascular and lymphatic disease
#85TRANSDERMAL FORMULATIONS
#86Anti-EGFR combinations for treating tumors
#87Regulators of the Endoplasmic Reticulum Proteostasis Network
#88Endoplasmic reticulum stress regulator comprising benzothiazoimidazolyl compound
#89COMBINATIONS OF POSITIVE ALLOSTERIC MODULATORS AND NICOTINIC ACETYLCHOLINE RECEPTOR AGONISTS FOR TREATING OCULAR CONDITIONS
#90Methods and compositions for treating mesothelioma and small lung cancer that express midkine
#91(3S)- AND (3R)-6,7-BIS(HYDROXYMETHYL)-1H,3H-PYRROLO[1,2-C]THIAZOLES AS P53 ACTIVATORS
#92A BIOMARKER AND TARGET FOR DIAGNOSIS, PROGNOSIS AND TREATMENT OF ANKYLOSING SPONDYLITIS
#93Method for predicting a subjects response to SLC modulator therapy
#94Method of treating peripheral neuropathy
#95SMALL MOLECULE IRE1-ALPHA INHIBITORS
#96Fused tricyclic compounds and uses thereof in medicine
#97ARYL HYDROCARBON RECEPTOR ANTAGONISTS AND METHODS OF USE
#98PAPD5 inhibitors and methods of use thereof
#99Methods and compositions for the treatment of tuberculosis
#100Mutant KRAS inhibitors
#101COMPOSITIONS FOR TREATING INFECTIVE ARTERIAL DISEASES AND RELATED CONDITIONS
#102SUBSTITUTED THIAZOLO-PYRIDINE COMPOUNDS AS MALT1 INHIBITORS
#103INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND/OR TRYPTOPHAN 2,3-DIOXYGENASE
#104Car activator agents for cyclophosphamide-based treatments of cancer
#105Macrocyclic therapeutic agents, methods of manufacture, and methods of treatment
#106Methods and compositions for treating mesothelioma and small lung cancer that express midkine
#107Mitofusin activators and uses thereof
#108TRPV4 antagonists
#109Fused thiazolopyrimidine derivatives as MNKs inhibitors
#110Antibacterial compounds
#111Inhibition of aminocylase 3 (AA3) in the treatment of cancer
#112Method of treating peripheral neuropathy
#113BAX activators and uses thereof in cancer therapy
#114HETEROCYCLIC COMPOUNDS AS HIV PROTEASE INHIBITORS
#115Stimulating platelet generation by activating mitochondrial biogenesis
#116Mutant KRas inhibitors
#117ANTIBACTERIAL COMPOUNDS
#118COMPOSITIONS AND METHODS OF USING STAT1/3 INHIBITORS WITH ONCOLYTIC HERPES VIRUS
#119Use of peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC1α) agonists to improve ex vivo expansion of tumor infiltrating lymphocytes (TILS)
#120Heterocyclic systems and pharmaceutical applications thereof
#121SUBSTITUTED THIAZOLO-PYRIDINE COMPOUNDS AS MALT1 INHIBITORS
#122Method for cellular RNA expression
#123Somatostatin receptor subtype 4 (SSTR4) agonists
#124MACROCYCLIC THERAPEUTIC AGENTS, METHODS OF MANUFACTURE, AND METHODS OF TREATMENT
#125TREATMENT OF FIBROTIC DISORDERS WITH JUN N-TERMINAL KINASE INHIBITORS
#126TRPV4 antagonists
#127Beta-amino pateamine a derivatives and methods for treating chronic lymphocytic leukemia
#128COMPOUNDS USEFUL FOR DECREASING INTERFERON LEVEL
#129SUBSTITUTED THIAZOLO-PYRIDINE COMPOUNDS AS MALT1 INHIBITORS
#130Methods and compositions for treating mesothelioma and small lung cancer that express midkine
#131Heterocyclic compounds as antibacterials
#132Antagonists of the thyroid-stimulating hormone receptor (TSHR)
#133Spirocyclic compounds as farnesoid X receptor modulators
#134Bridged bicyclic compounds as farnesoid X receptor modulators
#135Methods for treating renal disease
#136Anti-EGFR combinations for treating tumors
#137Small molecule IRE1-α inhibitors
#138Regulators of the endoplasmic reticulum proteostasis network
#139Fused thiazolopyrimidine derivatives as MNKS inhibitors
#140Compositions and methods employing FtsZ as a target for Albendazole sulfone
#141Compounds and methods for the targeted degradation of fetal liver kinase polypeptides
#142Forazolines, compositions thereof and uses thereof
#143BICYCLIC HETEROCYCLES AS INHIBITORS OF CHOLESTEROL ESTER TRANSFER PROTEIN
#144cGAS antagonist compounds
#145Antibacterial compounds
#146HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
#147Methods and compositions to treat cancer
#148Compositions and Methods employing Wolbachia FtsZ as a target for Albendazole sulfone
#149Mutant KRas inhibitors
#150Somatostatin receptor subtype 4 (SSTR4) agonists
#151Synthesis and utility of new capgroup largazole analogs
#152Method for preparing largazole analogs and uses thereof
#153Compositions and methods employing FtsZ as a target for Albendazole sulfone
#154Method of treating peripheral neuropathy
#155Composition for prevention or treatment of bronchial asthma comprising PKR inhibitor as active ingredient
#156IMIDAZOLOTHIAZOLE COMPOUNDS FOR THE TREATMENT OF DISEASE
#157TRANSDERMAL PARASITICIDAL FORMULATIONS
#158Method for using novel hydroxamic acid derivative and antibacterial substance in combination
#159Anti-viral compounds
#160Small molecule IRE1-α inhibitors
#161SMALL MOLECULE IRE1-ALPHA INHIBITORS
#162Compositions and methods of inhibiting metallo-β-lactamases
#163Macrocyclic compounds and methods of treatment
#164Sugar Derivatives Comprising Sulfur-Containing Moieties And Methods Of Making Same And Methods Of Using The Same For The Treatment Of MPS IIIC
#165METHOD FOR DETECTING OR TREATING TRIPLE NEGATIVE BREAST CANCER
#166Anti-depression compounds
#167Fused heterocyclic compound
#168Treatment of parasitic diseases using KDAC inhibitor compounds
#169Somatostatin receptor subtype 4 (SSTR4) agonists
#170Stable veterinary anthelmintic formulations
#171Methods for Treating Cognitive Disorders Using Inhibitors of Histone Deacetylase
#172Imidazothiazole derivatives as modulators of TNF activity
#173Tricyclic compounds and methods of making and using same
#174Various Compounds as Autophagy Stimulants
#175COMPOUND PERTAINING TO NEUROPOIESIS AND DRUG COMPOSITION
#176Benzo-thiazolo-imidazole compounds and uses thereof
#177Trace elements
#178Therapy for chronic idiopathic urticaria, anaphylaxis and angioedema
#179LEVIA : A New Injectable Parasiticidal Veterinary Formulation of Levamisole HCl and Ivermectin Solution.
#180FORAZOLINES, COMPOSITIONS THEREOF AND USES THEREOF
#181Use of REDD1 inhibitors to dissociate therapeutic and adverse atrophogenic effects of glucocorticoid receptor agonists
#1821,2- bis-sulfonamide derivatives as chemokine receptor modulators
#183Pharmaceutical combinations for the treatment of cancer
#184Small molecules to enhance P53 activity
#185Imidazothiazole sufonamides as nematicides
#186Method for Treating Peripheral Neuropathy
#187Cyclopropaneamine compound
#188METHODS AND COMPOSITIONS TO TREAT CANCER
#189MACROCYCLIC COMPOUNDS AND METHODS OF TREATMENT
#190Allosteric inhibitors of thymidylate synthase
#191Methods of treating proliferative diseases
#192Stable veterinary combination formulations of macrocyclic lactones and imidazothiazoles
#193O-GLCNACYLATION TREATMENT FOR ISCHEMIC BRAIN INJURY
#194TRANSDERMAL FORMULATIONS
#195Method for treating cerebral amyloid angiopathy using pharmacological chaperones to increase the activity of gangliosidases
#196ANTI-VIRAL COMPOUNDS
#197Nitrogen containing compounds
#198Cephalosporin derivatives and methods of use
#199Method for cellular RNA expression
#200Compositions and methods of inhibiting metallo-β-lactamases
#201Methods for treating renal disease
#202Compounds for treating HIV and methods for using the compounds
#203Transdermal parasiticidal formulations
#204Dosage Regime for Animal Treatment
#205METHODS FOR IDENTIFYING ANTI-CANCER COMPOUNDS
#206MACROCYCLIC COMPOUNDS AND METHODS OF TREATMENT
#207Imidazo bicyclic iminium compounds as antitumor agents
#208Nitrogen containing compounds
#209Compounds as inhibitors of diacylglycerol O-acyltransferase type 1 enzyme
#210Method of inducing an anti-HIV-1 immune response comprising administering a C5/TM-GP41 peptide dimer
#211IMIDAZOLOTHIAZOLE COMPOUNDS FOR THE TREATMENT OF DISEASE
#212Benzoxepin PI3K inhibitor compounds and methods of use
#213Ternary pesticidal mixtures
#214Glycosidase inhibitors
#215Nitrogen containing compounds
#216Non human animal model for ulcerative colitis and its main complications
#217Forazolines, compositions thereof and uses thereof
#218Benzopyran and benzoxepin PI3K inhibitor compounds and methods of use
#219Tri-heterocyclic derivatives, preparation process and uses thereof
#220Combination compositions and methods of treatment
#221Compounds for modulating TLR2
#2221-aza-bicyclo[3.3.1] non-4-yl)-[5-(1H-indol-5-yl)-heteroaryl]-amines as cholinergic ligands of the n-AChR for the treatment of psychotic and neurodegenerative disorders
#223Pyrano [3,2-D][1,3]thiazole as glycosidase inhibitors
#224Cyclopropaneamine compound
#225Anti-parasitic composition comprising a macrocyclic lactone and levamisole and method of treatment of parasitic infestation
#226Anthelmintic Formulations and Treatments
#227Methods for treating depression, neurodegeneration, inhibiting amyloid β deposition, delaying senescence, and extending life spans with heterocyclic compounds
#2281,6-diazabicyclo [3,2,1] octan-7-one derivatives and their use in the treatment of bacterial infections
#229Benzoxepin PI3K inhibitor compounds and methods of use
#230Method for preparing largazole analogs and uses thereof
#231Decoquinate, 4-hydroxyquinolones and napthoquinones combined with levamisole, Imidazothiazole, for the prevention and treatment of sarcocystosis and equine protozoal myeloencephalitis caused by Sarcocystis and Neospora and other apicomplexan protozoans.
#232Macrocyclic compounds and methods of treatment
#233SCREENING METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASES
#234Therapeutic compounds for blocking DNA synthesis of POX viruses
#235Lipoprotein lipase-activating compositions comprising benzene derivates
#236MACROCYCLIC COMPOUNDS AND METHODS OF TREATMENT
#237PHARMACEUTICAL COMPOSITIONS TO TREAT FIBROSIS
#238Tetrahydropyrazolo [3,4-b] azepine derivatives and their use as allosteric modulators of metabotropic glutamate receptors
#239CRTH2 MODULATORS
#240Di-azetidinyl diamide as monoacylglycerol lipase inhibitors
#241Di-azetidinyl diamide as monoacylglcerol lipase inhibitors
#242Cannabinoid Receptor Agonists
#243Cannabinoid Agonists
#244METHODS AND COMPOSITIONS FOR USE IN AQUACULTURE
#245Methods of treatment using combination therapy
#246Benzopyran and benzoxepin PI3K inhibitor compounds and methods of use
#247Pyrazolopyridine, pyrarolopyrazine, pyrazolopyrimidine, pyrazolothiophene and pyrazolothiazole compounds as MGLUR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
#248INJECTABLE FORMULATION OF A MACROCYCLIC LACTONE AND LEVAMISOLE
#249Antibacterial agents
#2505,5-fused arylene or heteroarylene hepatitis C virus inhibitors
#251Pyrazolopyridine, pyrazolopyrazine, pyrazolopyrimidine, pyrazolothiophene and pyrazolothiazole compounds as MGLUR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
#252Benzoxepin PI3K inhibitor compounds and methods of use
#253Therapeutic compounds for blocking DNA synthesis of pox viruses
#254Method for treating alzheimer's disease using pharmacological chaperones to increase the activity of gangliosidases
#255PHARMACEUTICAL COMBINATIONS, PHARMACEUTICAL COMPOSITIONS, MEDICAMENT AND METHOD FOR THE TREATMENT OF ANIMALS
#256Method for preparing largazole analogs and uses thereof
#257Methods of treating proliferative diseases
#258METHODS FOR TREATING DRUG-RESISTANT HEPATITIS C VIRUS INFECTION WITH A 5,5-FUSED ARYLENE OR HETEROARYLENE HEPATITIS C VIRUS INHIBITOR
#2591,2-bis-sulfonamide derivatives as chemokine receptor modulators
#260Imidazolothiazole compounds for the treatment of disease
#261ANTIBACTERIAL AGENTS
#262ANTI-ESTROGEN AND IMMUNE MODULATOR COMBINATIONS FOR TREATING BREAST CANCER
#263Inhibitors of bacterial type III secretion system
#264Macrocyclic compounds and methods of treatment
#265DI-AZETIDINYL DIAMIDE AS MONOACYLGLYCEROL LIPASE INHIBITORS
#266Substituted 5,6-dihydro-4H-thiazolo[4,5-E]indazoles and their use as positive allosteric modulators of metabotropic glutamate receptors
#267INHIBITION OF YOPS TRANSLOCATION
#268Diamine Derivatives
#269Compositions and dosage regimes comprising a clostridial vaccine and levamisole
#270METHODS FOR TREATING COGNITIVE DISORDERS USING INHIBITORS OF HISTONE DEACETYLASE
#271BOLUS
#272Bolus devices for the delivery of active agents to animals
#273Acetic acid amide derivative having inhibitory activity on endothelial lipase
#274Aralkyl substituted piperidine or piperazine derivatives and their use for treating schizophrenia
#275Compounds for modulating TLR2
#2765,5-fused arylene or heteroarylene hepatitis C virus inhibitors
#2774,5-dihydro-6-oxa-3-thia-1-aza-benzo[e]azulene compounds
#278MACROCYCLIC COMPOUNDS AND METHODS OF TREATMENT
#279Macrocyclic compounds and methods of treatment
#280Compounds as cannabinoid receptor ligands and uses thereof
#281Compounds as cannabinoid receptor ligands
#282Diamine Derivatives
#283COMPOSITIONS AND METHODS FOR INHIBITING THE ACTIVATION OF DSRNA-DEPENDENT PROTEIN KINASE AND TUMOR GROWTH INHIBITION
#284Benzoxepin PI3K inhibitor compounds and methods of use
#285LIPOPROTEIN LIPASE-ACTIVATING COMPOSITIONS COMPRISING BENZENE DERIVATIVES
#286Blood flow promoters for cauda equina tissues
#287Anti-estrogen and immune modulator combinations for treating breast cancer
#288Substituted benzamidines as antibacterial agents
#289Method of Decreasing Ubiquitylated Protein Levels
#290Method of using imidazolothiazole compounds for the treatment of disease
#291Methods of treatment using combination therapy
#292Compounds having activity in correcting mutant-CFTR processing and uses thereof
#293CSF-1R, Inhibitors, Compositions, and Methods of Use
#294Organic compounds
#295Antibacterial agents
#296Method of Inducing Cleavage of Amyloid Precursor Protein to Form a Novel Fragment
#297Macrolide antibiotics and their use for medical purposes
#298DIAMINE DERIVATIVES
#299Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
#300Method for treating benign prostate hyperplasia using resveratrol